Laura Mackay

Last updated

Laura Mackay
Laura Mackay, Royal Society of Victoria.jpg
Mackay in 2021
Alma mater University of Birmingham (PhD)
Known forIdentification and role of tissue-resident memory T cells
Awards
Scientific career
Fields Immunology
Institutions

Laura K. Mackay FAHMS is an internationally-recognised immunologist and Professor of Immunology at the University of Melbourne. Mackay is the Theme Leader in Immunology and Laboratory Head at the Peter Doherty Institute for Infection and Immunity. [4] [5] In 2022, she was the youngest ever Fellow elected to the Australian Academy of Health and Medical Sciences. [6] [7]

Contents

Early life and education

Mackay completed her undergraduate degree in Biological Science at the University of Warwick in 2004, Masters of Science at the University of Birmingham in 2005 and PhD under the supervision of Professor Alan B. Rickinson, an expert in the research of Epstein-Barr virus [8] in 2009. She undertook postdoctoral training with Professor Francis Carbone at The University of Melbourne. [9] During this period, she was the first to describe the molecular program and developmental features that underpin immune cell tissue residence. [10]

Career and Research

Mackay established her research Laboratory at the Peter Doherty Institute for Infection and Immunity at the University of Melbourne in 2016. She was appointed as Senior Lecturer in 2016, Associate-Professor in 2018, and full Professor in 2019. Mackay is also the Theme Leader in Immunology for the Peter Doherty Institute for Infection and Immunity. [5] [9] She has made significant contributions to the field of T cell memory and tissue immunity, with Mackay being listed as a Highly Cited Researcher™ annually since 2019. [11] [12]

In 2018, Mackay was appointed as the President of The Federation of Immunological Sciences of Asia-Oceania (FIMSA). [13] During her tenure, Mackay was the first female and youngest serving President of the organisation.

In 2022, Mackay was the youngest ever Fellow elected to the Australian Academy of Health and Medical Sciences, with the citation on election describing her as “an internationally recognised expert in T cell immunity, contributing landmark papers that have defined how memory T cell responses are generated in body tissues”. [14]

Scientific Outreach

Mackay serves on the Scientific Advisory Boards for journals Cell, Science Immunology and Trends in Immunology. [5] [9] She is the co-organiser of Global Immunotalks, an online seminar series posted on YouTube featuring world-leading immunologists presenting cutting-edge research, which aims to make the newest discoveries accessible to a global audience. [15] Mackay is also a co-host on National Triple R Radio science show, Einstein-A-Go-Go, communicating science and the latest research to the public. [16] Mackay has been interviewed by Science on diversity in STEM, [17] ABC Radio National Science Show on the influence of science on public good, [18] and had her career and research on tissue-resident memory T cells profiled by Pursuit. [19] [8]

Awards, honours and recognition

Selected publications

Related Research Articles

<span class="mw-page-title-main">T cell</span> White blood cells of the immune system

T cells are one of the important types of white blood cells of the immune system and play a central role in the adaptive immune response. T cells can be distinguished from other lymphocytes by the presence of a T-cell receptor (TCR) on their cell surface.

<span class="mw-page-title-main">Natural killer cell</span> Type of cytotoxic lymphocyte

Natural killer cells, also known as NK cells or large granular lymphocytes (LGL), are a type of cytotoxic lymphocyte critical to the innate immune system. They belong to the rapidly expanding family of known innate lymphoid cells (ILC) and represent 5–20% of all circulating lymphocytes in humans. The role of NK cells is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response. NK cells provide rapid responses to virus-infected cell and other intracellular pathogens acting at around 3 days after infection, and respond to tumor formation. Most immune cells detect the antigen presented on major histocompatibility complex (MHC) on infected cell surfaces, but NK cells can recognize and kill stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction. They were named "natural killers" because of the notion that they do not require activation to kill cells that are missing "self" markers of MHC class I. This role is especially important because harmful cells that are missing MHC I markers cannot be detected and destroyed by other immune cells, such as T lymphocyte cells.

<span class="mw-page-title-main">Polly Matzinger</span> French-born American immunologist

Polly Celine Eveline Matzinger is a French-born immunologist who proposed the danger model theory of how the immune system works.

The regulatory T cells (Tregs or Treg cells), formerly known as suppressor T cells, are a subpopulation of T cells that modulate the immune system, maintain tolerance to self-antigens, and prevent autoimmune disease. Treg cells are immunosuppressive and generally suppress or downregulate induction and proliferation of effector T cells. Treg cells express the biomarkers CD4, FOXP3, and CD25 and are thought to be derived from the same lineage as naïve CD4+ cells. Because effector T cells also express CD4 and CD25, Treg cells are very difficult to effectively discern from effector CD4+, making them difficult to study. Research has found that the cytokine transforming growth factor beta (TGF-β) is essential for Treg cells to differentiate from naïve CD4+ cells and is important in maintaining Treg cell homeostasis.

Memory T cells are a subset of T lymphocytes that might have some of the same functions as memory B cells. Their lineage is unclear.

Gamma delta T cells are T cells that have a γδ T-cell receptor (TCR) on their surface. Most T cells are αβ T cells with TCR composed of two glycoprotein chains called α (alpha) and β (beta) TCR chains. In contrast, γδ T cells have a TCR that is made up of one γ (gamma) chain and one δ (delta) chain. This group of T cells is usually less common than αβ T cells. Their highest abundance is in the gut mucosa, within a population of lymphocytes known as intraepithelial lymphocytes (IELs).

<span class="mw-page-title-main">Mucosal immunology</span> Field of study

Mucosal immunology is the study of immune system responses that occur at mucosal membranes of the intestines, the urogenital tract, and the respiratory system. The mucous membranes are in constant contact with microorganisms, food, and inhaled antigens. In healthy states, the mucosal immune system protects the organism against infectious pathogens and maintains a tolerance towards non-harmful commensal microbes and benign environmental substances. Disruption of this balance between tolerance and deprivation of pathogens can lead to pathological conditions such as food allergies, irritable bowel syndrome, susceptibility to infections, and more.

Nicholas P. Restifo is an American immunologist, physician and educator in cancer immunotherapy. Until July 2019, he was a tenured senior investigator in the intramural National Cancer Institute of the National Institutes of Health at Bethesda, Maryland. Nicholas was an executive vice president of research at Lyell based in San Francisco.

<span class="mw-page-title-main">Gabrielle Belz</span> Australian immunologist

Gabrielle T. Belz is an Australian molecular immunologist and viral immunologist. She is a faculty member of the Walter and Eliza Hall Institute of Medical Research, within the Molecular Immunology division. Belz has made important contributions to the understanding of immune system function, especially in relation to the molecular and cellular signalling pathways of immune response to viruses. Her research has focused on understanding the signals that drive the initial development of protective immunity against pathogen infections, such as influenza and herpes viruses. This includes research into how cytotoxic T cells recognise and remove virally-infected cells from the body following infection. Research into the description of the specific factors and response during infection will contribute towards the long-term development of vaccines for infectious disease, and the development of better treatments for autoimmune diseases.

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19 and Long COVID.

<span class="mw-page-title-main">Immune checkpoint</span> Regulators of the immune system

Immune checkpoints are regulators of the immune system. These pathways are crucial for self-tolerance, which prevents the immune system from attacking cells indiscriminately. However, some cancers can protect themselves from attack by stimulating immune checkpoint targets.

<span class="mw-page-title-main">ILC2</span>

ILC2 cells, or type 2 innate lymphoid cells are a type of innate lymphoid cell. Not to be confused with the ILC. They are derived from common lymphoid progenitor and belong to the lymphoid lineage. These cells lack antigen specific B or T cell receptor because of the lack of recombination activating gene. ILC2s produce type 2 cytokines and are involved in responses to helminths, allergens, some viruses, such as influenza virus and cancer.

Tissue-resident memory T cells or TRM cells represent a subset of a long-lived memory T cells that occupies epithelial, mucosal and other tissues without recirculating. TRM cells are transcriptionally, phenotypically and functionally distinct from central memory (TCM) and effector memory (TEM) T cells which recirculate between blood, the T cell zones of secondary lymphoid organ, lymph and nonlymphoid tissues. Moreover, TRM cells themself represent a diverse populations because of the specializations for the resident tissues. The main role of TRM cells is to provide superior protection against infection in extralymphoid tissues.

Immunological memory is the ability of the immune system to quickly and specifically recognize an antigen that the body has previously encountered and initiate a corresponding immune response. Generally, they are secondary, tertiary and other subsequent immune responses to the same antigen. The adaptive immune system and antigen-specific receptor generation are responsible for adaptive immune memory.

<span class="mw-page-title-main">Weiping Zou</span>

Weiping Zou is the Charles B. de Nancrede Professor of Pathology, Immunology, Biology, and Surgery at the University of Michigan. He is a scientist noted for his work regarding understanding the nature of human tumor immune responses and developing mechanism-informed combination therapies for cancer. He has developed an international reputation in human tumor immunosuppressive mechanisms in the tumor microenvironment.

<span class="mw-page-title-main">Franca Ronchese</span> Italian-New Zealand immunologist

Franca Ronchese is an Italian-New Zealand immunologist. She currently leads the immune cell biology programme at the Malaghan Institute of Medical Research in Wellington, New Zealand and is a research professor at Victoria University of Wellington.

Miram Merad is a French-Algerian professor in Cancer immunology and the Director of the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY. She is the corecipient of the 2018 William B. Coley Award for Distinguished Research in Basic Immunology and a member of the United States National Academy of Sciences and the National Academy of Medicine.

Wendy Havran was an American immunologist at the Scripps Research Institute. She specialized in T cells, showing that they are scarce in certain areas of the body.

Thomas S. Kupper is an American physician, academic, and clinician. His work with clinical and research experience spans dermatology, cutaneous oncology, and immunology. He is the Thomas B. Fitzpatrick Professor at Harvard Medical School, and chairs the Departments of Dermatology at Brigham and Women's Hospital. He also leads the Cutaneous Oncology Disease Center at the Dana Farber Cancer Institute.

Roslyn A. Kemp is a New Zealand immunologist, and as of 2023 is a full professor at the University of Otago. Her research focuses on T cells, mucosal and tumour immune responses, inflammation and T cell memory.

References

  1. 1 2 Department of Industry, Science (16 October 2019). "2019 Frank Fenner Prize for Life Scientist of the Year". Department of Industry, Science, Energy and Resources. Retrieved 17 August 2020.
  2. 1 2 "2019 Australian Museum Eureka Prize winners". The Australian Museum. Retrieved 17 August 2020.
  3. 1 2 "Laura Mackay, Ph.D." Human Vaccines Project. Retrieved 17 August 2020.
  4. 1 2 "Professor Laura Mackay | Doherty Website". www.doherty.edu.au. Retrieved 17 August 2020.
  5. 1 2 3 "Prof Laura Mackay". findanexpert.unimelb.edu.au. Retrieved 9 May 2023.
  6. Riley, Robyn. "Immunologist's remarkable journey to high accolade". Herald Sun. Retrieved 9 May 2023.
  7. Weeden, Emilia (19 October 2022). "Professor Laura Mackay becomes youngest fellow elected to the Australian Academy of Health and Medical Sciences". School of Biomedical Sciences. Retrieved 9 May 2023.
  8. 1 2 "Fighting infection with curiosity". Pursuit. 7 March 2020. Retrieved 14 July 2023.
  9. 1 2 3 "Professor Laura Mackay | Doherty Website". www.doherty.edu.au. Retrieved 3 July 2023.
  10. Fehervari, Zoltan (6 December 2022). "An elegant defence". Nature Research.
  11. "Web of Science". www.webofscience.com. Retrieved 10 November 2023.
  12. Institute, The Doherty (23 November 2022). "Doherty Institute's highly cited researchers in 2022". www.doherty.edu.au. Retrieved 10 November 2023.
  13. Institute, The Doherty (22 November 2018). "Dr Laura Mackay appointed first female president of Asia-Pacific immunology body". www.doherty.edu.au. Retrieved 10 November 2023.
  14. "Professor Laura Mackay - AAHMS". aahms.org. 14 October 2022. Retrieved 3 July 2023.
  15. "2023 Organizers". Global Immunotalks: Free virtual immunology seminars. Retrieved 10 November 2023.
  16. "Programs: Einstein A Go-Go — Triple R 102.7FM, Melbourne Independent Radio". www.rrr.org.au. Retrieved 10 November 2023.
  17. "The importance of diversity in STEM: A conversation with Dr. Laura Mackay". www.science.org. Retrieved 7 April 2022.
  18. "Science and the public good". ABC Radio National. 3 September 2021. Retrieved 7 April 2022.
  19. Melbourne, Andrew Trounson, University of (5 August 2018). "The cells giving our immune system more punch". Pursuit. Retrieved 7 April 2022.{{cite web}}: CS1 maint: multiple names: authors list (link)
  20. Institute, The Doherty (19 October 2023). "Immunology trailblazer Professor Laura Mackay named inaugural AAMRI Rising Star". www.doherty.edu.au. Retrieved 30 October 2023.
  21. Rowney, Katie (6 September 2023). "First responders in our skin and gut revealed: Prof Laura Mackay - AAHMS". aahms.org. Retrieved 16 October 2023.
  22. "Award winner redefining the field of immunological memory". LEO Foundation. 10 May 2023. Retrieved 30 May 2023.
  23. Shanahan, Rachel (14 October 2022). "Professor Laura Mackay". Australian Academy of Health and Medical Sciences. Retrieved 23 October 2022.
  24. Sandler, Lanny (28 April 2023). "Woodward Medallists". Research Funding. Retrieved 30 May 2023.
  25. "Mackay, Laura – Biographical entry". Encyclopedia of Australian Science. Retrieved 3 November 2020.
  26. "Dr Laura Mackay". AIPS. Retrieved 7 April 2022.